Cordycepin as a potential pharmacological inhibitor of pro-fibrotic pathways in systemic sclerosis
Abstract Cordycepin has already been studied in vitro and in vivo as potential treatment of different organ fibrosis, such as kidney and renal fibrosis. In the presented study, the authors...
